Although we demonstrated that IGFBP3 expression was significantly decreased in ESCC tissues (Fig. 6H, I), which implies that IGFBP3 exhibits antitumor properties in ESCC cells, some reports have demonstrated that IGFBP3 could promote ESCC progression [55]. The gene discussed is IGFBP3; the disease is esophageal squamous cell carcinoma.